// App-Quantinova.ai

P2.147 : Pharmacokinetic Modeling Study to Evaluate Two Intranasal Formulations of Sumatriptan for Nasal vs Gastrointestinal Tract Absorption (P2.147)

Researchers

Presenter

  • Mary Lor

Principal Investigators

  • Laura E. Pope

  • Jean R. Lavigne

  • Kenneth J. Shulman

  • Per G. Djupesland

  • Joao Siffert

Medical Centers

  • Avanir Pharmaceuticals, Inc. Aliso Viejo CA United States

  • Celerion Montreal Canada

  • OptiNose AS Oslo Norway

  • Former Employee of Avanir Pharmaceuticals, Inc. Aliso Viejo CA United States

Locations

  • Canada

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Sumatriptan

Outcome

  • N/A

Study Design

  • Pharmacokinetics

  • Cross Over

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved